You are here
- Home
- Drug Products
- All Drug Products
A Phase I, Single Centre, Double-Blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Inhaled Doses of AZD8683 in Healthy Volunteers and COPD patients.
- Disease
- chronic obstructive pulmonary disease
- Drug Name
- AZD8683
- Generic Name
- AZD8683
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D1883C00002
- Study Id
- D1883C00002
- ClinicalTrials.gov ID
- NCT01584739
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
